Middle age is where the conditions these drugs treat, obesity and type 2 diabetes, become common, and where most people still have private insurance or the income to cover a drug that has listed at more than $1,000 a month
Outside of its use in diabetes treatment, it has additionally been discovered to aid with weight loss
The better approach is individualized care that considers metabolic health, lifestyle, medical history, and long-term function
One study published in 2022 warned that non-obese patients who simply desired minor weight loss could be prone to abusing these drugs as image- and performance-enhancing substances
Despite these preclinical and therapeutic advancements in gut-derived peptides, particularly multiagonists, the molecular mechanisms driving metabolic reprogramming and remodeling of target tissues in the context of an inter-organ crosstalk that leads to fat mass reduction and increased EE have not been addressed
Patients also notice reduced food obsession and increased energy, which enhance their capacity to enjoy life and stay active
